Andrew Gitkin

Andrew Gitkin is a managing director and head of West Coast biotechnology investment banking at Piper Jaffray. Mr. Gitkin has 20+ years of experience, most recently at Moelis & Company, where he was a senior vice president in the life sciences investment banking group. Amongst his previous positions, Mr. Gitkin was a managing member of Saddle Point Asset Management and a vice president at Tavistock Life Sciences where he was responsible for managing Boxer Capital, a healthcare-focused investment partnership. Mr. Gitkin was also a senior healthcare equity research analyst at UBS and SalomonSmithBarney where he was awarded rankings by Institutional Investor and Greenwich Associates. Gitkin holds a bachelor’s degree in business administration from the Goizueta School of Business at Emory University.